Blueprint Medicines Corp (BPMC) — Capital Reinvestment Ratio
Blueprint Medicines Corp (BPMC) has a Capital Reinvestment Ratio of 0.00x as of September 2020, meaning it reinvests 0% of its operating cash flow ($622.33 Million) in capital expenditures ($6.00K). See BPMC net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Blueprint Medicines Corp Capital Reinvestment Ratio (2020–2020)
This chart tracks Blueprint Medicines Corp's Capital Reinvestment Ratio across 1 annual periods. Check BPMC cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Blueprint Medicines Corp (2020–2020)
Year-by-year Capital Reinvestment Ratio for Blueprint Medicines Corp from 2020 to 2020. For live market cap and broader valuation context, see BPMC market cap.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 0.01x | $387.04 Million | $3.16 Million | — |